Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Exelixis (EXEL) Forecast
NewsEarningsExelixis (EXEL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Exelixis (NASDAQ:EXEL) Stock Quotes, Forecast and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.
Who are Exelixis (EXEL) competitors?
Other companies in Exelixis’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Exelixis (EXEL) stock?
Exelixis has a consensus price target of $30.80.
What is the current price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $34.78 last updated November 21, 2024 at 1:19 PM EST.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q4 earnings are confirmed for Tuesday, February 4, 2025.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.